Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 3

Results: 15

The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 389, doi. 10.1007/s00262-007-0381-5

By:

Thompson, James A.;
Srivastava, Minu K.;
Bosch, Jacobus J.;
Clements, Virginia K.;
Ksander, Bruce R.;
Ostrand-Rosenberg, Suzanne

Publication type:

Article

Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.

Published in:

2008

By:

Kronik, Natalie;
Kogan, Yuri;
Vainstein, Vladimir;
Agur, Zvia

Publication type:

Correction Notice

Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 411, doi. 10.1007/s00262-007-0383-3

By:

Müller, Tina;
Uherek, Christoph;
Maki, Guitta;
Kai UweChow;
Schimpf, Annemarie;
Klingemann, Hans-Georg;
Tonn, Torsten;
Wels, Winfried S.

Publication type:

Article

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 289, doi. 10.1007/s00262-007-0378-0

By:

Britten, C. M.;
Gouttefangeas, C.;
Welters, M. J. P.;
Pawelec, G.;
Koch, S.;
Ottensmeier, C.;
Mander, A.;
Walter, S.;
Paschen, A.;
Müller-Berghaus, J.;
Haas, I.;
Mackensen, A.;
Køllgaard, T.;
thor Straten, P.;
Schmitt, M.;
Giannopoulos, K.;
Maier, R.;
Veelken, H.;
Bertinetti, C.;
Konur, A.

Publication type:

Article

Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 285, doi. 10.1007/s00262-007-0379-z

By:

Britten, C. M.;
Janetzki, S.;
van der Burg, S. H;
Gouttefangeas, C.;
Hoos, A.

Publication type:

Article

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 303, doi. 10.1007/s00262-007-0380-6

By:

Janetzki, Sylvia;
Panageas, Katherine;
Ben-Porat, Leah;
Boyer, Jean;
Britten, Cedrik;
Clay, Timothy;
Kalos, Michael;
Maecker, Holden;
Romero, Pedro;
Yuan, Jianda;
Martin Kast, W.;
Hoos, Axel

Publication type:

Article

Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 347, doi. 10.1007/s00262-007-0374-4

By:

Ryan, Elizabeth P.;
Bushnell, Timothy P.;
Friedman, Alan E.;
Rahman, Irfan;
Phipps, Richard P.

Publication type:

Article

Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 325, doi. 10.1007/s00262-007-0372-6

By:

Prado-Garcia, Heriberto;
Aguilar-Cazares, Dolores;
Meneses-Flores, Manuel;
Morales-Fuentes, Jorge;
Lopez-Gonzalez, Jose

Publication type:

Article

Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 379, doi. 10.1007/s00262-007-0377-1

By:

Liljefors, Maria;
Nilsson, Bo;
Mellstedt, Håkan;
Frödin, Jan-Erik

Publication type:

Article

Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 425, doi. 10.1007/s00262-007-0387-z

By:

Kronik, Natalie;
Kogan, Yuri;
Vainstein, Vladimir;
Agur, Zvia

Publication type:

Article

Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 367, doi. 10.1007/s00262-007-0376-2

By:

Qing-An Yuan;
Robinson, Matthew;
Simmons, Heidi;
Russeva, Maria;
Adams, Gregory

Publication type:

Article

Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 337, doi. 10.1007/s00262-007-0373-5

By:

Uchida, Tetsuro;
Horiguchi, Shigetoshi;
Tanaka, Yuriko;
Yamamoto, Heizaburo;
Kunii, Naoki;
Motohashi, Shinichiro;
Taniguchi, Masaru;
Nakayama, Toshinori;
Okamoto, Yoshitaka

Publication type:

Article

Potential contribution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 359, doi. 10.1007/s00262-007-0375-3

By:

Teruel, Antonia;
Romero, Marcela;
Cacalano, Nicholas A.;
Head, Christian;
Jewett, Anahid

Publication type:

Article

CD8+ T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 399, doi. 10.1007/s00262-007-0382-4

By:

Vikman, Sofia;
Giandomenico, Valeria;
Sommaggio, Roberta;
Öberg, Kjell;
Essand, Magnus;
Tötterman, Thomas

Publication type:

Article

Plant-derived EpCAM antigen induces protective anti-cancer response.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 317, doi. 10.1007/s00262-007-0366-4

By:

Brodzik, Robert;
Spitsin, Sergei;
Golovkin, Max;
Bandurska, Katarzyna;
Portocarrero, Carla;
Okulicz, Monika;
Steplewski, Zenon;
Koprowski, Hilary

Publication type:

Article

Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 3

The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4<sup>+</sup> T lymphocytes.

Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.

Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells.

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8<sup>+</sup> T lymphocytes by structural and functional assays.

Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).

Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells.

Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.

Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity.

Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.

Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning.

Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer.

Potential contribution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion.

CD8<sup>+</sup> T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients.

Plant-derived EpCAM antigen induces protective anti-cancer response.